Evidence map›Paper›PMID 31226101›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Improvement of Gut Microbiota by Inhibition of P38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Rats with Severe Acute Pancreatitis.

You-Dong Wan, Rui-Xue Zhu, Zhong-Zheng Bian, Xin-Ting Pan

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Frontiers in pharmacology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Downregulating Gasdermin D Reduces Severe Acute Pancreatitis Associated with Pyroptosis.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

You-Dong WanDepartment of Emergency Intensive Care, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Rui-Xue ZhuDepartment of Ultrasound, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Zhong-Zheng BianDepartment of Emergency Intensive Care, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Xin-Ting PanDepartment of Emergency Intensive Care, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Affiliated Hospital of Qingdao University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Gut microbiota dysbiosis plays a key role in pathogenesis of severe acute pancreatitis (SAP). In this study, we explored the protective effects of the p38 MAPK inhibitor, SB203580, against gut inflammation and microbiota dysbiosis induced by pancreatic duct injection with 3.5% sodium taurocholate in an SAP rat model. MATERIAL AND METHODS Ninety male Sprague-Dawley rats were randomly assigned to sham-operated, SAP model, and SAP plus SB203580 groups (n=30/group). Histological examination was conducted to assess gut and pancreatitis injury. The levels of amylase, D-lactate, diamine oxidase, tumor necrosis factor alpha, IL-6, IL-1ß, and phospho-p38MAPK in the plasma and intestine were evaluated at 3, 6, or 12 h after SAP induction. The gut microbiome was investigated based on16S rDNA gene sequencing at 12 h after SAP induction. RESULTS Histological examination revealed edema and inflammatory infiltrations in the pancreas and distal ileum. The expression of tumor necrosis factor alpha, IL-1ß, and IL-6 in plasma and distal ileum was increased in the SAP group, which were restored after treatment with SB203580. Significantly lower bacterial diversity and richness was found in the SAP group. In the SAP group, the abundance of Bacteroidetes and Firmicutes was decreased, and there was a higher proportion of Proteobacteria at the phylum level. The SAP plus SB203580 group exhibited significantly less damage to the gut microbiota, with higher bacterial diversity and a more normal proportion of intestinal microbiota. CONCLUSIONS SB203580 mediated suppression of the p38 MAPK signaling pathway via reduced gut inflammatory response and microbiota dysbiosis.

Indexed as

Acute DiseaseAnimalsDisease Models, AnimalEnzyme InhibitorsGastrointestinal MicrobiomeImidazolesInflammationInterleukin-1betaMaleMAP Kinase Signaling Systemp38 Mitogen-Activated Protein KinasesPancreatitisPyridinesRatsRats, Sprague-DawleyTaurocholic AcidEnzyme InhibitorsImidazolesInterleukin-1betap38 Mitogen-Activated Protein KinasesPyridinesSB 203580Taurocholic AcidTumor Necrosis Factor-alpha

Identifiers

PMID31226101
PMCPMC6599419
OpenAlexW2953083275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.